Figure 2: Survival times according to BCR-ABL status and BAALC expression in adult B- precursor ALL patients. (A, B) OS in BCR-ABL- negative, BCR-ABL+ respectively, (C, D) DFS in BCR-ABL- negative and BCR-ABL+ respectively.